Exploring AI tools and multi-omics for precision medicine in lung cancer therapy
- 6 June 2025
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 84, 135-157
Abstract
No abstract availableKeywords
This publication has 219 references indexed in Scilit:
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung AdenocarcinomaJAMA Surgery, 2021
- FHITlow/pHER2high signature in non‐small cell lung cancer is predictive of anti‐HER2 molecule efficacyThe Journal of Pathology, 2020
- Construction of a Novel Bispecific Antibody to Enhance Antitumor Activity against Lung CancerAdvanced Materials, 2018
- Metabolomic profiling of human lung tumor tissues – nucleotide metabolism as a candidate for therapeutic interventions and biomarkersMolecular Oncology, 2018
- A novel protein‐based prognostic signature improves risk stratification to guide clinical management in early‐stage lung adenocarcinoma patientsThe Journal of Pathology, 2018
- Radiomics analysis of pulmonary nodules in low‐dose CT for early detection of lung cancerMedical Physics, 2018
- Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers—A mini‐reviewGenes, Chromosomes and Cancer, 2016
- Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air PollutionJAMA, 2002
- Small adenocarcinoma of the lung. Histologic characteristics and prognosisCancer, 1995